Immunofluorescence, Extracellular: (Left) JS-1 cells transiently transfected human ADAM9 were stained with ADAM9 Monoclonal Antibody (CSB0071) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (Top right) JS-1 cells transiently transfected with an empty control vector stained with ADAM9 Monoclonal Antibody. (Bottom right) Isotype control: JS-1 cells transfected with human ADAM9 and stained with control MAb.

Immunofluorescence, Intracellular: (Left) JS-1 cells transiently transfected human ADAM9 were permeabilized and stained with ADAM9 Monoclonal Antibody (CSB0071) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (Top right) JS-1 cells transiently transfected with an empty control vector stained with ADAM9 Monoclonal Antibody. (Bottom right) Isotype control: JS-1 cells transfected with human ADAM9 and stained with control MAb.

Membrane Proteome Specificity: The specificity of ADAM9 Monoclonal Antibody (CSB0071) was tested on the Membrane Proteome Arrayâ„¢ and shown to be specific for human ADAM9. The Membrane Proteome Arrayâ„¢ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Arrayâ„¢ represents the industry standard for determining the binding specificity of antibodies and other protein ligands.